Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Tyme Technologies stock | $1.1

Own Tyme Technologies stock in just a few minutes.

Posted

Fact checked

Tyme Technologies, Inc is a biotechnology business based in the US. Tyme Technologies shares (TYME) are listed on the NASDAQ and all prices are listed in US Dollars. Tyme Technologies employs 18 staff and has a market cap (total outstanding shares value) of USD$139.9 million.

How to buy shares in Tyme Technologies

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Tyme Technologies. Find the stock by name or ticker symbol: TYME. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Tyme Technologies reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$1.1, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Tyme Technologies, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Tyme Technologies. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Tyme Technologies share price

Use our graph to track the performance of TYME stocks over time.

Tyme Technologies shares at a glance

Information last updated 2020-11-30.
Latest market closeUSD$1.1
52-week rangeUSD$0.85 - USD$2.04
50-day moving average USD$0.9557
200-day moving average USD$1.1734
Wall St. target priceUSD$8.17
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.28

Buy Tyme Technologies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Tyme Technologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Tyme Technologies price performance over time

Historical closes compared with the close of $1.1 from 2020-12-09

1 week (2021-01-05) -20.29%
1 month (2020-12-12) N/A
3 months (2020-10-12) 8.91%
6 months (2020-07-12) N/A
1 year (2020-01-12) N/A
2 years (2019-01-12) N/A
3 years (2018-01-12) 6.69
5 years (2016-01-12) N/A

Tyme Technologies financials

Gross profit TTM USD$0
Return on assets TTM -89.55%
Return on equity TTM -260.08%
Profit margin 0%
Book value $0.111
Market capitalisation USD$139.9 million

TTM: trailing 12 months

Shorting Tyme Technologies shares

There are currently 3.5 million Tyme Technologies shares held short by investors – that's known as Tyme Technologies's "short interest". This figure is 0.8% up from 3.4 million last month.

There are a few different ways that this level of interest in shorting Tyme Technologies shares can be evaluated.

Tyme Technologies's "short interest ratio" (SIR)

Tyme Technologies's "short interest ratio" (SIR) is the quantity of Tyme Technologies shares currently shorted divided by the average quantity of Tyme Technologies shares traded daily (recently around 256343.75928678). Tyme Technologies's SIR currently stands at 13.46. In other words for every 100,000 Tyme Technologies shares traded daily on the market, roughly 13460 shares are currently held short.

However Tyme Technologies's short interest can also be evaluated against the total number of Tyme Technologies shares, or, against the total number of tradable Tyme Technologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Tyme Technologies's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Tyme Technologies shares in existence, roughly 30 shares are currently held short) or 0.0437% of the tradable shares (for every 100,000 tradable Tyme Technologies shares, roughly 44 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Tyme Technologies.

Find out more about how you can short Tyme Technologies stock.

Tyme Technologies share dividends

We're not expecting Tyme Technologies to pay a dividend over the next 12 months.

Have Tyme Technologies's shares ever split?

Tyme Technologies's shares were split on a 4:1 basis on 26 September 2014. So if you had owned 1 share the day before before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your Tyme Technologies shares – just the quantity. However, indirectly, the new 75% lower share price could have impacted the market appetite for Tyme Technologies shares which in turn could have impacted Tyme Technologies's share price.

Tyme Technologies share price volatility

Over the last 12 months, Tyme Technologies's shares have ranged in value from as little as $0.85 up to $2.04. A popular way to gauge a stock's volatility is its "beta".

TYME.US volatility(beta: 0.77)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tyme Technologies's is 0.7661. This would suggest that Tyme Technologies's shares are less volatile than average (for this exchange).

Tyme Technologies overview

Tyme Technologies, Inc., a clinical-stage biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead candidate is the SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, lung, breast, prostate, sarcoma, and lymphoma. The company also offers TYME-18, a CMBT compound that is in preclinical stage for the treatment of solid tumors. Tyme Technologies, Inc. has a research collaboration with NYU Langone Health to advance the development of treatments for patients with metastatic cancers, including pancreatic cancer, as well as with Mayo Clinic; and a strategic collaboration with Eagle Pharmaceuticals, Inc. to advance oral SM-88 for the treatment of patients with cancer. The company was formerly known as Global Group Enterprises Corp. Tyme Technologies, Inc. was founded in 2011 and is headquartered in New York, New York.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site